Spruce Biosciences, Inc. (SPRB) PT Lowered to $1.50 at RBC Capital Following Study Fail Dec 11, 2024 08:12AM
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 13, 2024 04:01PM
Spruce Biosciences to Participate in May Investor Conferences May 1, 2024 04:05PM
RBC Capital Downgrades Spruce Biosciences, Inc. (SPRB) to Sector Perform, 'Trial Miss Puts Tilda’ Future in Flux' Mar 14, 2024 04:33AM
Spruce Biosciences to Participate in May Investor Conferences May 2, 2023 04:05PM


May 11, 2022 04:01PM Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 3, 2022 04:05PM Spruce Biosciences to Participate in May Investor Conferences
May 13, 2021 04:05PM Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference
Nov 3, 2020 06:07AM UPDATE: RBC Capital Starts Spruce Biosciences, Inc. (SPRB) at Outperform
Oct 14, 2020 04:05PM Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 9, 2020 11:40AM Spruce Biosciences (SPRB) IPO Opens 21% Higher